Investment
Features
FeesSafety
Academy
More
Pluang+

Compare HCA Health Inc (HCA) vs Novavax Inc (NVAX) Price & Performance

HCA Health IncTrade
Novavax IncTrade

Price performance (Past 24H)

Key statistics

HCA Health Inc vs Novavax Inc — how do they compare? HCA Health Inc trades at $411 (market cap $89.08B), while Novavax Inc trades at $7.94 (market cap $1.31B). The key difference: HCA Health Inc is far larger — about 68× Novavax Inc's market cap, and HCA Health Inc pays a 0.76% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.

HCANVAX
Market Cap
$89.08B$1.31B
Sector
HealthHealth
52-Week High
$545.13$11.19
52-Week Low
$361.32$6.22
Enterprise Value
$139.62B$889.30M
Dividend Yield
0.76%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

HCA Health Inc

No Aura AI signal available yet.

Novavax Inc

Novavax (NVAX) trades at $7.89, down 0.75% on the day, with a bullish technical signal despite mixed indicators. The company reported a strong Q2 2026 earnings beat, raising its full-year revenue outlook, while maintaining a low valuation with a P/E of 3.14 and EV/EBITDA of 1.72. However, negative net income margin and shareholder equity highlight financial challenges.

The outlook is cautiously optimistic, driven by partnership milestones with Sanofi and cost reductions, but risks include persistent cash burn and competitive vaccine market pressures. Analyst consensus leans bullish with 74% buy ratings, suggesting potential upside if execution improves.

Returns comparison

Trailing returns across standard periods

About HCA Health Inc

HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.

Read more on HCA

About Novavax Inc

Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.

Read more on NVAX